Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 15;126(20):4614-4615.
doi: 10.1002/cncr.33111. Epub 2020 Aug 7.

Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals

Nicolas Penel  1   2 , Thomas Ryckewaert  1 , Diane Pannier  1
Affiliations
Comment

Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals

Nicolas Penel et al. Cancer. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. D’Ambrosio L, Touati N, Blay JY, et al. Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer. 2020;126:2637-2647. doi:10.1002/cncr.32795
    1. Penel N, Italiano A, Isambert N, et al. Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy. Ann Oncol. 2010;21:1361-1365. doi:10.1093/annonc/mdp485
    1. van Oosterom AT, Mouridsen HT, Nielsen OS, et al. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer. 2002;38:2397-2406. doi:10.1016/s0959-8049(02)00491-4
    1. Gronchi A, Palmerini E, Quagliuolo V, et al. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups. J Clin Oncol. 2020;38:2178-2186. doi:10.1200/JCO.19.03289
    1. Chudasama P, Mughal SS, Sanders MA, et al. Integrative genomic and transcriptomic analysis of leiomyosarcoma. Nat Commun. 2018;9:144. doi:10.1038/s41467-017-02602-0

MeSH terms

LinkOut - more resources